METOPROLOL TARTRATE
Generic: METOPROLOL TARTRATE
HospiraManufacturer
INTRAVENOUSRoute
METOPROLOL TARTRATEActive Substance
2008-04-29Original Approval
METOPROLOL TARTRATE is FDA application ANDA078085, sponsored by HOSPIRA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2021-03-15
Metoprolol Tartrate and Hydrochlorothiazide Tablets, USP 50 mg/25 mg 100 Tablets Rx only NDC 62332-115-31 Manufactured fCGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II2021-09-09
Metoprolol Tartrate Tablets USP 100 mg, 1000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA Inc. 279 PrincPresence of Foreign Substance: Product complaints received for the presence of metal wire in one tab
Class II2024-05-06
Metoprolol Tartrate Tablets USP, 25mg, 1000 count bottle, Rx only, distributed by: TruPharma, LLC, Tampa, FL 33609, ManuPresence of Foreign Substance: metal in tablet
Class II2021-12-31
Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distributed by: TruPharma, LLC. Tampa, FL 33609; MComplaint received of foreign matter (metal) embedded in tablet.
Top Reported Reactions
1
FATIGUE
16,494 reports
2
DYSPNOEA
14,516 reports
3
DIARRHOEA
14,098 reports
4
NAUSEA
13,864 reports
5
DRUG INEFFECTIVE
12,916 reports
6
DIZZINESS
12,034 reports
7
OFF LABEL USE
10,276 reports
8
DEATH
10,018 reports
9
ASTHENIA
9,636 reports
10
PAIN
9,333 reports